Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation

被引:68
作者
Lomaestro, BM
Drusano, GL
机构
[1] Albany Med Ctr Hosp, Albany, NY 12208 USA
[2] Ordway Res Inst, Albany, NY 12208 USA
关键词
D O I
10.1128/AAC.49.1.461-463.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A Monte Carlo simulation demonstrated that 1 g of meropenem (MEM) every 8 h (q8h) (3-h infusion) has a higher target attainment rate against Pseudomonas aeruginosa than either 500 mg of MEM q8h (3-h infusion) or 0.5 g of imipenem-cilastatin (I-C) q6h (1-h infusion). For other pathogens, 500 mg of MEM q8h was equivalent or superior to I-C.
引用
收藏
页码:461 / 463
页数:3
相关论文
共 12 条
[1]  
BAUERFEIND A, 1997, 37 INT C ANT AG CHEM
[2]  
DARGENIO DZ, ADAPT 2 USERS GUIDE
[3]   Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection [J].
Domenig, C ;
Traunmüller, F ;
Kozek, S ;
Wisser, W ;
Klepetko, W ;
Steininger, R ;
Spiss, C ;
Thalhammer, F .
TRANSPLANTATION, 2001, 71 (06) :744-745
[4]   Prevention of resistance: A goal for dose selection for antimicrobial agents [J].
Drusano, GL .
CLINICAL INFECTIOUS DISEASES, 2003, 36 :S42-S50
[5]   MULTIPLE-DOSE PHARMACOKINETICS OF IMIPENEM-CILASTATIN [J].
DRUSANO, GL ;
STANDIFORD, HC ;
BUSTAMANTE, C ;
FORREST, A ;
RIVERA, G ;
LESLIE, J ;
TATEM, B ;
DELAPORTAS, D ;
MACGREGOR, RR ;
SCHIMPFF, SC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :715-721
[6]  
DRUSANO GL, 1995, SCAND J INFECT DIS, P11
[7]   Relationships between antimicrobial effect and area under the concentration-time curve as a basis for comparison of modes of antibiotic administration: Meropenem bolus injections versus continuous infusions [J].
Firsov, AA ;
Mattie, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :352-356
[8]   Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model [J].
Keil, S ;
Wiedemann, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1215-1219
[9]  
SORGEL F, 1997, 37 INT C ANT AG CHEM
[10]   Continuous infusion versus intermittent administration of meropenem in critically ill patients [J].
Thalhammer, F ;
Traunmüller, F ;
El Menyawi, I ;
Frass, M ;
Hollenstein, UM ;
Locker, GJ ;
Stoiser, B ;
Staudinger, T ;
Thalhammer-Scherrer, R ;
Burgmann, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :523-527